SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $221,000 | -32.8% | 934,220 | -0.8% | 0.00% | – |
Q4 2015 | $329,000 | -79.9% | 941,667 | +0.0% | 0.00% | – |
Q3 2015 | $1,634,000 | -23.1% | 941,271 | -1.0% | 0.00% | – |
Q2 2015 | $2,124,000 | +38.2% | 950,644 | +20.2% | 0.00% | – |
Q1 2015 | $1,537,000 | -26.6% | 790,866 | -0.1% | 0.00% | – |
Q4 2014 | $2,095,000 | -10.1% | 791,411 | +2.2% | 0.00% | – |
Q3 2014 | $2,330,000 | -25.1% | 774,506 | +1.9% | 0.00% | – |
Q2 2014 | $3,110,000 | -7.2% | 759,989 | -2.3% | 0.00% | – |
Q1 2014 | $3,352,000 | -60.5% | 778,198 | -35.0% | 0.00% | -100.0% |
Q4 2013 | $8,486,000 | +121.4% | 1,197,560 | +97.2% | 0.00% | – |
Q3 2013 | $3,833,000 | +26.3% | 607,275 | -0.2% | 0.00% | – |
Q2 2013 | $3,034,000 | – | 608,371 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
CAXTON CORP | 52,000 | $116,000 | 0.12% |
Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
Roundview Capital LLC | 29,100 | $65,000 | 0.02% |